A pilot study for evaluating hypoxia area in pancreas cancer by 18F-FMISO PET/CT

A pilot study for evaluating hypoxia area in pancreas cancer by 18F-FMISO PET/CT - A pilot study for pancreas cancer by FMISO-PET/CT

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000016065

Enrollment

Registered

2015-01-01

Start date

2015-01-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pancreas cancer

Interventions

18F-FMISO-PET/CT

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) Patients with written informed consent 2) Patients who were diagnosed or suspected as pancreas cancer 3) Patients who have already acquired or were planned to acquire 18F-FDG-PET/CT

Exclusion criteria

Exclusion criteria: 1) Patients with pregnancy or possibility of pregnancy 2) Patients who cannot keep supine position during the PET exam of approximately 30 minutes 3) Patients who were considered to be inappropriate to join this study

Design outcomes

Primary

Measure	Time frame
To evaluate the acquisition protocol of 18F-FMISO-PET/CT for pancreas cancer To compare the result of 18F-FMISO-PET/CT with the other imaging modalities To compare the result of 18F-FMISO-PET/CT with the clinical outcome	—

Countries

Japan

Contacts

Public ContactTomohiko Yamane

Saitama International Medical Center, Saitama Medical University Department of Nuclear Medicine

t_yamane@saitama-med.ac.jp042-984-4111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026